Our hydrogel-based DishGel delivery of VEGF-C-activated lymphatic growth and mitigated arthritis pathologies and orofacial pain, which provides a feasible and reliable method of functional perturbation of the lymphatic system in the TMJ. This evidence concerns the gene VEGFC and Arthritis.